A. Lucumi et al., SENSITIVITY OF LEISHMANIA-VIANNIA-PANAMENSIS TO PENTAVALENT ANTIMONY IS CORRELATED WITH THE FORMATION OF CLEAVABLE DNA-PROTEIN COMPLEXES, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 1990-1995
The emergence of Leishmania less sensitive to pentavalent antimonial a
gents (SbVs), the report of inhibition of purified topoisomerase I of
Leishmania donovani by sodium stibogluconate (Pentostam), and the unce
rtain mechanism of action of antimonial drugs prompted an evaluation o
f SbVs in the stabilization of cleavable complexes in promastigotes of
Leishmania (Viannia). The effect of camptothecin, an inhibitor of top
oisomerase, and additive-free meglumine antimoniate (Glucantime) on th
e stabilization of cleavable DNA-protein complexes associated with the
inhibition of topoisomerase was assessed in the human promonocytic ce
ll line U-937, promastigotes of L. (Viannia) panamensis selected for S
bV resistance in vitro, and the corresponding wild-type strain. The st
abilization of cleavable complexes and the 50% effective dose (ED50) o
f SbVs for parasites isolated from patients with relapses were also ev
aluated. The median ED50 for the wild-type strain was 16.7 mu g of SbV
/ml, while that of the line selected for resistance was 209.5 mu g of
SbV/ml, Treatment with both meglumine antimoniate and sodium stibogluc
onate (20 to 200 mu g of SbV/ml) stabilized DNA-protein complexes in t
he wild-type strain but not the resistant line, The ED(50)s of the SbV
s for Leishmania strains from patients with relapses was comparable to
those for the line selected for in vitro resistance, and DNA-protein
complexes were not stabilized by exposure to meglumine antimoniate, Cl
eavable complexes were observed in all Leishmania strains treated with
camptothecin, Camptothecin stabilized cleavable complexes in U-937 ce
lls; SbVs did not. The selective effect of the SbVs on the stabilizati
on of DNA-protein complexes in Leishmania and the loss of this effect
in naturally resistant or experimentally derived SbV-resistant Leishma
nia suggest that topoisomerase may be a target of antimonial drugs.